1. Combined locoregional-immunotherapy for liver cancer
Tim F. Greten, Michal Mauda-Havakuk, Bernd Heinrich, Firouzeh Korangy, Bradford J. Wood 
Journal of Hepatology 
Volume 70, Issue 5, Pages (May 2019)
DOI: /j.jhep
Copyright © Terms and Conditions

2. Fig. 1
Spontaneous HCC developing in chronically hepatitis infected woodchucks. (A) Contrast-enhanced CT scan shows large heterogenous tumour with robust arterial blood supply (B). Gross pathology of liver and tumour (tumour edges demarcated by white arrows, margins of the tumour behind the liver demarcated by dashed line). HCC, hepatocellular carcinoma.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © Terms and Conditions

3. Fig. 2
Overview of considerations for future research studies combining immunotherapy with locoregional therapies. cTACE, conventional TACE; HIFU, high-intensity focussed ultrasound; IRE, irreversible electroporation; RFA, radiofrequency ablation; TACE, transarterial chemoembolization; TAE, transarterial embolization.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © Terms and Conditions

4. Fig. 3
Tumour response in patient with HCC upon TACE + tremelimumab treatment in lesion not treated by TACE. HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © Terms and Conditions